BioWorld Asia

May 7, 2003

European Sector Experiences Falloff In Revenues, Employees

LONDON - The European biotechnology sector in 2002 saw revenues and employee numbers fall for the first time in a decade, according to Ernst & Young's 10th annual survey of the sector. (BioWorld International) Read More

Phytopharm Enters Potentially Lucrative Deal With Yamanouchi

Estrogen Receptor Modulators May Have Anticancer Role, Study Shows

Vernalis Raising £14.1 Million As It Negotiates Sale Of Company

Israeli Biotech Continues Growth With Private, Government Support

Irish University-Industry Program Draws Funding, Foreign Partners

Serono Disagrees With Rejection Of Serostim For AIDS Wasting

Protherics Paying £17.9M In Notes, Shares For Acquisition Of Enact

Zealand, Wyeth Collaborate On Gap Junction Modulators

Hybrigenics Acquires Dutch Firm Semaia In 'Friendly' Stock Deal

Sloning Raises EUR4.3M In Second Round For DNA Cloning Program

Other News To Note

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

Keros reports beneficial effects of RKER-065 in ALS model

BioWorld Science

Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.

News in brief

BioWorld Asia

BioWorld Asia briefs for March 17, 2026

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...